Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
NCT03576287 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2018-07-03
Summary
This study will evaluate the anti-pruritic effect of apremilast in patients with known PN.
Conditions
- Prurigo Nodularis
Interventions
- DRUG
-
Apremilast Oral Product
Apremilast
Sponsors & Collaborators
-
Tanja Todberg, MD
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2019-12-01
- Completion
- 2019-12-01
Countries
- Denmark
Study Locations
More Related Trials
-
Apremilast for Atopic Dermatitis - A Pilot Study in Adults
NCT01393158 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib
NCT05451316 ·Status: COMPLETED
-
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
NCT01232985 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)
NCT04183335 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
NCT01552629 ·Status: COMPLETED ·Phase: PHASE2
-
Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus
NCT01905631 ·Status: COMPLETED ·Phase: PHASE2
-
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
NCT07223697 ·Status: RECRUITING ·Phase: PHASE2
-
A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
NCT00666302 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis
NCT04975438 ·Status: COMPLETED ·Phase: PHASE1
-
Apremilast and Moderate to Severe Chronic Hand Dermatitis
NCT03741933 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis
NCT04693195 ·Status: COMPLETED ·Phase: PHASE2
-
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
NCT05032859 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT05507580 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
NCT02068352 ·Status: COMPLETED ·Phase: PHASE2
-
Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis
NCT04823130 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
NCT05935085 ·Status: TERMINATED ·Phase: PHASE2
-
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
NCT02975206 ·Status: COMPLETED ·Phase: PHASE2
-
An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
NCT07027527 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
NCT05014568 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
NCT03293030 ·Status: COMPLETED ·Phase: PHASE4
-
Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa
NCT02695212 ·Status: COMPLETED ·Phase: PHASE2
-
Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis
NCT00121381 ·Status: COMPLETED ·Phase: PHASE4